Kyrtsonis, MC Vassilakopoulos, TP Papadogiannis, A Tzenou, T and Kalpadakis, C Antoniadis, A Dimopoulou, MN Siakantaris, MP Kokoris, SI Dimitriadou, EM Angelopoulou, MK Plata, E and Tsaftaridis, P Pangalis, GA, Serum soluble syndecan-1 levels at diagnosis constitute an independent
prognostic factor of survival in myeloma that may further differentiate
patients within the ISS stages, Blood advances, (106), 951A, 2005, AMER SOC HEMATOLOGY,